Overall, the significant links between chemotherapy, radiation, and KRAS mutations align with the biological behavior of KRAS-mutant lung cancer, underlining the necessity for alternative treatments like chemotherapy and radiation in these patients. This evidence concerns the gene KRAS and lung cancer.